.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Deloitte
Queensland Health
Covington
Johnson and Johnson
AstraZeneca
Cantor Fitzgerald
Colorcon
Medtronic
Cerilliant

Generated: July 23, 2017

DrugPatentWatch Database Preview

Trazodone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for trazodone hydrochloride and what is the scope of trazodone hydrochloride freedom to operate?

Trazodone hydrochloride
is the generic ingredient in four branded drugs marketed by Mylan, Pragma Pharms Llc, Angelini Pharma, Watson Labs, Alvogen, Mylan Pharms Inc, Quantum Pharmics, Teva Pharms Usa, Pliva, Sun Pharm Inds, Am Therap, Teva, Apotex, Torrent Pharms Ltd, Sandoz, Aurolife Pharma Llc, Usl Pharma, Vintage, and Apotex Inc, and is included in twenty-nine NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Trazodone hydrochloride has ninety-two patent family members in thirty-three countries.

There are thirteen drug master file entries for trazodone hydrochloride. Forty-three suppliers are listed for this compound.

Summary for Generic Name: trazodone hydrochloride

Tradenames:4
Patents:4
Applicants:19
NDAs:29
Drug Master File Entries: see list13
Suppliers / Packagers: see list43
Bulk Api Vendors: see list57
Clinical Trials: see list2,277
Patent Applications: see list1,550
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:trazodone hydrochloride at DailyMed

Pharmacology for Ingredient: trazodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL070858-001Oct 10, 1986DISCNNoNo► Subscribe► Subscribe
Watson Labs
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL071112-001Nov 17, 1986DISCNNoNo► Subscribe► Subscribe
Usl Pharma
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL070492-001Apr 29, 1987DISCNNoNo► Subscribe► Subscribe
Am Therap
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL071140-001Oct 29, 1986DISCNNoNo► Subscribe► Subscribe
Torrent Pharms Ltd
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL202180-002Nov 27, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: trazodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pragma Pharms Llc
DESYREL
trazodone hydrochloride
TABLET;ORAL018207-003Mar 25, 19854,215,104► Subscribe
Pragma Pharms Llc
DESYREL
trazodone hydrochloride
TABLET;ORAL018207-003Mar 25, 19854,258,027► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: trazodone hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,414,919Sustained drug release composition► Subscribe
8,314,236Trazodone and trazodone hydrochloride in purified form► Subscribe
8,795,723Sustained drug release compositions► Subscribe
9,439,866Trazodone composition for once a day administration► Subscribe
8,962,019Sustained drug release composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: trazodone hydrochloride

Country Document Number Estimated Expiration
Poland365634► Subscribe
Germany60120413► Subscribe
World Intellectual Property Organization (WIPO)2007048220► Subscribe
Portugal1931346► Subscribe
World Intellectual Property Organization (WIPO)2007048219► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
McKinsey
Deloitte
Mallinckrodt
Express Scripts
Moodys
Colorcon
Accenture
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot